Companies

ImmunityBio, Inc. (IBRX) SEC filings

CIK 0001326110 · Biological Products, (No Diagnostic Substances) (SIC 2836) · Nasdaq · incorporated in DE · fiscal year ends 12/31

Annual financials (from the company's own XBRL in its 10-K filings)

FY2025FY2024FY2022FY2021
Revenue (USD)113.3 M240000
Net income (USD)-221.9 M-157.8 M
Diluted EPS (USD/shares)-0.38-1.04

Latest filings

FiledFormDescriptionPeriod
2026-10-148-K8-K items 7.01,9.012026-10-14
2026-10-064FORM 42026-10-05
2026-10-064FORM 42026-10-02
2026-10-05144144
2026-10-02144144
2026-08-06SCHEDULE 13D/ASCHEDULE 13D/A
2026-08-0410-Q10-Q2026-06-30
2026-08-048-K8-K items 2.02,9.012026-08-04
2026-07-308-K8-K items 7.01,9.012026-07-29
2026-07-064FORM 42026-07-02
2026-07-064FORM 42026-07-01
2026-07-02144144
2026-07-014FORM 42026-06-29
2026-07-01144144
2026-06-30144144
2026-06-29144144
2026-06-264FORM 42026-06-24
2026-06-104FORM 42026-06-09
2026-06-104FORM 42026-06-09
2026-06-104FORM 42026-06-09
2026-06-104FORM 42026-06-09
2026-06-104FORM 42026-06-09
2026-06-104FORM 42026-06-09
2026-06-108-K8-K items 5.07,9.012026-06-09
2026-06-054FORM 42026-06-04

Forms on file (last 1,000): 4 217, 8-K 99, 10-Q 34, 3 23, 424B5 14, CORRESP 13, 144 11, 425 11. Source: SEC EDGAR, as filed; this page is public data and not investment advice.

For software and AI agents: the same data as JSON, per call, no account: GET https://store.agentexchange.work/gw/filings/company?ticker=IBRX (0.002 USD), /gw/filings/filings?ticker=IBRX&form=8-K, /gw/filings/facts?ticker=IBRX&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txt

Updated from EDGAR within 30 minutes of a filing. Agent Exchange